Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Dec 15;100(12):3019–3026. doi: 10.1172/JCI119856

An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus.

J A James 1, K M Kaufman 1, A D Farris 1, E Taylor-Albert 1, T J Lehman 1, J B Harley 1
PMCID: PMC508514  PMID: 9399948

Abstract

An unknown environmental agent has been suspected to induce systemic lupus erythematosus (lupus) in man. Prompted by our recent immunochemical findings, we sought evidence for an association between Epstein-Barr virus infection and lupus. Because the vast majority of adults have been infected with Epstein-Barr virus, we chose to study children and young adults. Virtually all (116 of 117, or 99%) of these young patients had seroconverted against Epstein-Barr virus, as compared with only 70% (107 of 153) of their controls (odds ratio 49.9, 95% confidence interval 9.3-1025, P < 0. 00000000001). The difference in the rate of Epstein-Barr virus seroconversion could not be explained by serum IgG level or by cross-reacting anti-Sm/nRNP autoantibodies. No similar difference was found in the seroconversion rates against four other herpes viruses. An assay for Epstein-Barr viral DNA in peripheral blood lymphocytes established Epstein-Barr virus infection in the peripheral blood of all 32 of the lupus patients tested, while only 23 of the 32 matched controls were infected (odds ratio > 10, 95% confidence interval 2.53-infinity, P < 0.002). When considered with other evidence supporting a relationship between Epstein-Barr virus and lupus, these data are consistent with, but do not in themselves establish, Epstein-Barr virus infection as an etiologic factor in lupus.

Full Text

The Full Text of this article is available as a PDF (330.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Hamilton R. G., Reveille J. D., Bias W. B., Harley J. B., Reichlin M. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum. 1989 Apr;32(4):413–419. doi: 10.1002/anr.1780320410. [DOI] [PubMed] [Google Scholar]
  2. Evans A. S., Rothfield N. F., Niederman J. C. Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet. 1971 Jan 23;1(7691):167–168. doi: 10.1016/s0140-6736(71)91937-4. [DOI] [PubMed] [Google Scholar]
  3. Gregory C. D., Dive C., Henderson S., Smith C. A., Williams G. T., Gordon J., Rickinson A. B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature. 1991 Feb 14;349(6310):612–614. doi: 10.1038/349612a0. [DOI] [PubMed] [Google Scholar]
  4. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8479–8483. doi: 10.1073/pnas.90.18.8479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. James J. A., Gross T., Scofield R. H., Harley J. B. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med. 1995 Feb 1;181(2):453–461. doi: 10.1084/jem.181.2.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. James J. A., Harley J. B. Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns. J Immunol. 1996 May 15;156(10):4018–4026. [PubMed] [Google Scholar]
  7. James J. A., Harley J. B. Linear epitope mapping of an Sm B/B' polypeptide. J Immunol. 1992 Apr 1;148(7):2074–2079. [PubMed] [Google Scholar]
  8. James J. A., Mamula M. J., Harley J. B. Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRL lpr/lpr antibodies. Clin Exp Immunol. 1994 Dec;98(3):419–426. doi: 10.1111/j.1365-2249.1994.tb05507.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. James J. A., Scofield R. H., Harley J. B. Lupus humoral autoimmunity after short peptide immunization. Ann N Y Acad Sci. 1997 Apr 5;815:124–127. doi: 10.1111/j.1749-6632.1997.tb52054.x. [DOI] [PubMed] [Google Scholar]
  10. Kitagawa H., Iho S., Yokochi T., Hoshino T. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus. Immunol Lett. 1988 Mar;17(3):249–252. doi: 10.1016/0165-2478(88)90037-5. [DOI] [PubMed] [Google Scholar]
  11. Klippel J. H., Decker J. L. Epstein-Barr virus antibody and lymphocyte tubuloreticular structures in systemic lupus erythematosus. Lancet. 1973 Nov 10;2(7837):1057–1058. doi: 10.1016/s0140-6736(73)92662-7. [DOI] [PubMed] [Google Scholar]
  12. Lerner M. R., Andrews N. C., Miller G., Steitz J. A. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1981 Feb;78(2):805–809. doi: 10.1073/pnas.78.2.805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P. M., Klein G., Kurilla M. G., Masucci M. G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 1995 Jun 22;375(6533):685–688. doi: 10.1038/375685a0. [DOI] [PubMed] [Google Scholar]
  14. Liu Y., de Waal Malefyt R., Briere F., Parham C., Bridon J. M., Banchereau J., Moore K. W., Xu J. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol. 1997 Jan 15;158(2):604–613. [PubMed] [Google Scholar]
  15. Marchini B., Dolcher M. P., Sabbatini A., Klein G., Migliorini P. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. J Autoimmun. 1994 Apr;7(2):179–191. doi: 10.1006/jaut.1994.1014. [DOI] [PubMed] [Google Scholar]
  16. Miyashita E. M., Yang B., Lam K. M., Crawford D. H., Thorley-Lawson D. A. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 1995 Feb 24;80(4):593–601. doi: 10.1016/0092-8674(95)90513-8. [DOI] [PubMed] [Google Scholar]
  17. Miyazaki I., Cheung R. K., Dosch H. M. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp Med. 1993 Aug 1;178(2):439–447. doi: 10.1084/jem.178.2.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ngou J., Graafland H., Segondy M. Antibodies against polypeptides of purified Epstein-Barr virus in sera from patients with connective tissue diseases. J Autoimmun. 1992 Apr;5(2):243–249. doi: 10.1016/0896-8411(92)90203-3. [DOI] [PubMed] [Google Scholar]
  19. Ngou J., Segondy M., Seigneurin J. M., Graafland H. Antibody responses against polypeptide components of Epstein-Barr virus-induced early diffuse antigen in patients with connective tissue diseases. J Med Virol. 1990 Sep;32(1):39–46. doi: 10.1002/jmv.1890320107. [DOI] [PubMed] [Google Scholar]
  20. Petersen J., Rhodes G., Roudier J., Vaughan J. H. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1990 Jul;33(7):993–1000. doi: 10.1002/art.1780330711. [DOI] [PubMed] [Google Scholar]
  21. Rivkin E., Vella M. J., Lahita R. G. A heterogeneous immune response to an SmD-like epitope by SLE patients. J Autoimmun. 1994 Feb;7(1):119–132. doi: 10.1006/jaut.1994.1009. [DOI] [PubMed] [Google Scholar]
  22. Rothfield N. F., Evans A. S., Niederman J. C. Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus. Ann Rheum Dis. 1973 May;32(3):238–246. doi: 10.1136/ard.32.3.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sabbatini A., Bombardieri S., Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol. 1993 May;23(5):1146–1152. doi: 10.1002/eji.1830230525. [DOI] [PubMed] [Google Scholar]
  24. Saito I., Servenius B., Compton T., Fox R. I. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med. 1989 Jun 1;169(6):2191–2198. doi: 10.1084/jem.169.6.2191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sculley D. G., Sculley T. B., Pope J. H. Reactions of sera from patients with rheumatoid arthritis, systemic lupus erythematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides. J Gen Virol. 1986 Oct;67(Pt 10):2253–2258. doi: 10.1099/0022-1317-67-10-2253. [DOI] [PubMed] [Google Scholar]
  27. Stafford H. A., Anderson C. J., Reichlin M. Unmasking of anti-ribosomal P autoantibodies in healthy individuals. J Immunol. 1995 Sep 1;155(5):2754–2761. [PubMed] [Google Scholar]
  28. Strasser A., Whittingham S., Vaux D. L., Bath M. L., Adams J. M., Cory S., Harris A. W. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8661–8665. doi: 10.1073/pnas.88.19.8661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Taga K., Chretien J., Cherney B., Diaz L., Brown M., Tosato G. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J Clin Invest. 1994 Jul;94(1):251–260. doi: 10.1172/JCI117315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  31. Tsokos G. C., Magrath I. T., Balow J. E. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. J Immunol. 1983 Oct;131(4):1797–1801. [PubMed] [Google Scholar]
  32. Vaughan J. H., Nguyen M. D., Valbracht J. R., Patrick K., Rhodes G. H. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J Clin Invest. 1995 Mar;95(3):1316–1327. doi: 10.1172/JCI117782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Vaughan J. H. The Epstein-Barr virus in autoimmunity. Springer Semin Immunopathol. 1995;17(2-3):203–230. doi: 10.1007/BF00196166. [DOI] [PubMed] [Google Scholar]
  34. Yokochi T., Yanagawa A., Kimura Y., Mizushima Y. High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol. 1989 Aug;16(8):1029–1032. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES